News Releases

News Release | Arizona PIRG | Higher Ed

Student Loan Interest Rate Deal Will Make Things Worse

Senate lawmakers last night agreed to a deal on student loan reform that could be voted on as early as Tuesday of next week. The new proposal makes long-term changes to the student loan system, which address Congress’ budget crisis by charging student loan borrowers more. This deal prompted Arizona PIRG to call on Arizona Senators McCain and Flake to vote against the bill.

News Release | Arizona PIRG | Tax

Ag Subsidies Pay for 20 Twinkies per Taxpayer, But Only Half of an Apple Apiece

Federal subsidies for commodity crops are subsidizing junk food additives like high-fructose corn syrup, at a rate that would buy 20 Twinkies for each taxpayer every year, according to a new report from Arizona PIRG, “Apples to Twinkies 2013.” Meanwhile, limited subsidies for fresh fruits and vegetables would buy one half of an apple per taxpayer.

News Release | Arizona PIRG Education Fund | Health Care

As New Health Insurance Rate Increases Become Effective, Consumer Group Provides Analysis & Offers Recommendations

Today, the Arizona PIRG Education Fund released A Glimpse into Arizona’s Health Insurance Rate Review Program. The document provides an initial analysis on how effectively Arizona is reviewing proposed health insurance rate increases for the individual market since taking over that responsibility from the federal government.

News Release | Arizona PIRG | Higher Ed

Interest Rates for Arizona Student Loan Borrowers Double

Due to Congressional inaction, the interest rates on federally subsidized student loans doubled on July 1 from 3.4-percent to 6.8-percent. According to the Arizona Public Interest Research Group (Arizona PIRG), the change will translate into a $902 increase in debt per Arizona college student, per loan.  However, because most new student loans are issued in August and September, Congress can still pass a retroactive fix.

News Release | Arizona PIRG | Health Care

Big Pharma’s Pay-for-Delay Deals Take a Hit

Big Pharma’s controversial “pay-for-delay” agreements took a hit today. In FTC v. Actavis, the U.S. Supreme Court ruled that the FTC’s case against the payoff keeping generic AndroGel from the market can move ahead in the lower courts.

Pages

Subscribe to More News

support us

Your donation supports Arizona PIRG's work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.

CONSUMER ALERTS

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.